{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:52:39Z","timestamp":1790779959322,"version":"4.1.0"},"reference-count":123,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T00:00:00Z","timestamp":1699833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T00:00:00Z","timestamp":1699833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Infectious Disease Medical Center startup fund","award":["YZ-B2022011-1"],"award-info":[{"award-number":["YZ-B2022011-1"]}]},{"name":"Jinan Microecological Biomedicine Shandong Laboratory project","award":["JNL-2022050B"],"award-info":[{"award-number":["JNL-2022050B"]}]},{"name":"Leading Innovative and Entrepreneur Team Introduction Program of Zhejiang","award":["No. 2021R01012"],"award-info":[{"award-number":["No. 2021R01012"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s00284-023-03524-5","type":"journal-article","created":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T16:02:33Z","timestamp":1699891353000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Stenotrophomonas maltophilia: An Urgent Threat with Increasing Antibiotic Resistance"],"prefix":"10.1007","volume":"81","author":[{"given":"Jiaying","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanghui","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,13]]},"reference":[{"issue":"10","key":"3524_CR1","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1002\/ppul.23781","volume":"52","author":"EE Barsky","year":"2017","unstructured":"Barsky EE, Williams KA, Priebe GP et al (2017) Incident Stenotrophomonas maltophilia infection and lung function decline in cystic fibrosis. Pediatr Pulmonol 52(10):1276\u20131282. https:\/\/doi.org\/10.1002\/ppul.23781","journal-title":"Pediatr Pulmonol"},{"issue":"5","key":"3524_CR2","doi-asserted-by":"publisher","first-page":"610","DOI":"10.3390\/genes12050610","volume":"12","author":"Q Menetrey","year":"2021","unstructured":"Menetrey Q, Sorlin P, Jumas-Bilak E et al (2021) Achromobacter xylosoxidans and Stenotrophomonas maltophilia: emerging pathogens well-armed for life in the cystic fibrosis patients\u2019 lung. Genes 12(5):610","journal-title":"Genes"},{"issue":"2","key":"3524_CR3","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1128\/AAC.48.2.666-669.2004","volume":"48","author":"R Barbolla","year":"2004","unstructured":"Barbolla R, Catalano M, Orman BE et al (2004) Class 1 integrons increase trimethoprim-sulfamethoxazole MICs against epidemiologically unrelated Stenotrophomonas maltophilia isolates. Antimicrob Agents Chemother 48(2):666\u2013669. https:\/\/doi.org\/10.1128\/AAC.48.2.666-669.2004","journal-title":"Antimicrob Agents Chemother"},{"key":"3524_CR4","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00559-20","author":"M Biagi","year":"2020","unstructured":"Biagi M, Vialichka A, Jurkovic M et al (2020) Activity of cefiderocol alone and in combination with levofloxacin, minocycline, polymyxin B, or trimethoprim-sulfamethoxazole against multidrug-resistant Stenotrophomonas maltophilia. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/AAC.00559-20","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"3524_CR5","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00030-19","volume":"34","author":"JS Brooke","year":"2021","unstructured":"Brooke JS (2021) Advances in the microbiology of Stenotrophomonas maltophilia. Clin Microbiol Rev 34(3):e0003019. https:\/\/doi.org\/10.1128\/CMR.00030-19","journal-title":"Clin Microbiol Rev"},{"issue":"5","key":"3524_CR6","doi-asserted-by":"publisher","first-page":"ofaa141","DOI":"10.1093\/ofid\/ofaa141","volume":"7","author":"B Cai","year":"2020","unstructured":"Cai B, Tillotson G, Benjumea D et al (2020) The burden of bloodstream infections due to Stenotrophomonas maltophilia in the United States: a large, retrospective database study. Open Forum Infect Dis 7(5):ofaa141. https:\/\/doi.org\/10.1093\/ofid\/ofaa141","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"3524_CR7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1128\/CMR.00019-11","volume":"25","author":"JS Brooke","year":"2012","unstructured":"Brooke JS (2012) Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin Microbiol Rev 25(1):2\u201341. https:\/\/doi.org\/10.1128\/CMR.00019-11","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"3524_CR8","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1099\/0096266X-13-3-133","volume":"12","author":"RHAE Leifson","year":"1963","unstructured":"Leifson RHAE (1963) A description of the type strain of Pseudomonas maltophilia. Int J Syst Evolut Microbiol 12(3):6. https:\/\/doi.org\/10.1099\/0096266X-13-3-133","journal-title":"Int J Syst Evolut Microbiol"},{"key":"3524_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1099\/00221287-26-1-123","volume":"26","author":"R Hugh","year":"1961","unstructured":"Hugh R, Ryschenkow E (1961) Pseudomonas maltophilia, an alcaligenes-like species. J Gen Microbiol 26:123\u2013132. https:\/\/doi.org\/10.1099\/00221287-26-1-123","journal-title":"J Gen Microbiol"},{"key":"3524_CR10","doi-asserted-by":"crossref","unstructured":"Swings J, Vos PD, Mooter MVD, et al. Transfer of Pseudomonas maltophilia Hugh 1981 to the Genus Xanthomonas as Xanthomonas maltophilia (Hugh 1981) comb. nov. Int J Syst Bacteriol 1983. 409\u201313.","DOI":"10.1099\/00207713-33-2-409"},{"issue":"2","key":"3524_CR11","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1574-6968.1993.tb06508.x","volume":"113","author":"M Martine","year":"1993","unstructured":"Martine M (1993) Fast classification of plant-associated bacteria in the Xanthomonas genus. FEMS Microbiol Lett 113(2):161\u2013165. https:\/\/doi.org\/10.1111\/j.1574-6968.1993.tb06508.x","journal-title":"FEMS Microbiol Lett"},{"issue":"7","key":"3524_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0067103","volume":"8","author":"P Alavi","year":"2013","unstructured":"Alavi P, M\u00fcller H, Cardinale M et al (2013) The DSF quorum sensing system controls the positive influence of Stenotrophomonas maltophilia on plants. PLoS ONE 8(7):e67103. https:\/\/doi.org\/10.1371\/journal.pone.0067103","journal-title":"PLoS ONE"},{"issue":"1","key":"3524_CR13","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1186\/1471-2164-15-482","volume":"15","author":"P Alavi","year":"2014","unstructured":"Alavi P, Starcher MR, Thallinger GG et al (2014) Stenotrophomonas comparative genomics reveals genes and functions that differentiate beneficial and pathogenic bacteria. BMC Genomics 15(1):482. https:\/\/doi.org\/10.1186\/1471-2164-15-482","journal-title":"BMC Genomics"},{"key":"3524_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.01511","author":"JS Brooke","year":"2017","unstructured":"Brooke JS, Di Bonaventura G, Berg G et al (2017) Editorial: a multidisciplinary look at Stenotrophomonas maltophilia: an emerging multi-drug-resistant global opportunistic pathogen. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2017.01511","journal-title":"Front Microbiol"},{"key":"3524_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.00620","author":"T Cernava","year":"2015","unstructured":"Cernava T, M\u00fcller H, Aschenbrenner IA et al (2015) Analyzing the antagonistic potential of the lichen microbiome against pathogens by bridging metagenomic with culture studies. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2015.00620","journal-title":"Front Microbiol"},{"issue":"7","key":"3524_CR16","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.tim.2018.04.006","volume":"26","author":"SQ An","year":"2018","unstructured":"An SQ, Berg G (2018) Stenotrophomonas maltophilia. Trends Microbiol 26(7):637\u2013638. https:\/\/doi.org\/10.1016\/j.tim.2018.04.006","journal-title":"Trends Microbiol"},{"issue":"6","key":"3524_CR17","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00203-006-0115-7","volume":"185","author":"M Hagemann","year":"2006","unstructured":"Hagemann M, Hasse D, Berg G (2006) Detection of a phage genome carrying a zonula occludens like toxin gene (zot) in clinical isolates of Stenotrophomonas maltophilia. Arch Microbiol 185(6):449\u2013458. https:\/\/doi.org\/10.1007\/s00203-006-0115-7","journal-title":"Arch Microbiol"},{"key":"3524_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.02190","author":"F Lira","year":"2017","unstructured":"Lira F, Berg G, Mart\u00ednez JL (2017) Double-face meets the bacterial world: the opportunistic pathogen Stenotrophomonas maltophilia. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2017.02190","journal-title":"Front Microbiol"},{"issue":"6","key":"3524_CR19","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1128\/aem.02817-09","volume":"76","author":"MC Turrientes","year":"2010","unstructured":"Turrientes MC, Baquero MR, S\u00e1nchez MB et al (2010) Polymorphic mutation frequencies of clinical and environmental Stenotrophomonas maltophilia populations. Appl Environ Microbiol 76(6):1746\u20131758. https:\/\/doi.org\/10.1128\/aem.02817-09","journal-title":"Appl Environ Microbiol"},{"issue":"3","key":"3524_CR20","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1128\/JCM.02204-10","volume":"49","author":"LA Carmody","year":"2011","unstructured":"Carmody LA, Spilker T, LiPuma JJ (2011) Reassessment of Stenotrophomonas maltophilia phenotype. J Clin Microbiol 49(3):1101\u20131103. https:\/\/doi.org\/10.1128\/JCM.02204-10","journal-title":"J Clin Microbiol"},{"key":"3524_CR21","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/714232","author":"P Mukherjee","year":"2013","unstructured":"Mukherjee P, Roy P (2013) Persistent organic pollutants induced protein expression and immunocrossreactivity by Stenotrophomonas maltophilia PM102: a prospective bioremediating candidate. Biomed Res Int. https:\/\/doi.org\/10.1155\/2013\/714232","journal-title":"Biomed Res Int"},{"key":"3524_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.biortech.2019.122114","author":"Y Jia","year":"2019","unstructured":"Jia Y, Zhou M, Chen Y et al (2019) Carbon selection for nitrogen degradation pathway by Stenotrophomonas maltophilia: based on the balances of nitrogen, carbon and electron. Bioresour Technol. https:\/\/doi.org\/10.1016\/j.biortech.2019.122114","journal-title":"Bioresour Technol"},{"key":"3524_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2018.00401","author":"V Kalidasan","year":"2018","unstructured":"Kalidasan V, Joseph N, Kumar S et al (2018) Iron and virulence in Stenotrophomonas maltophilia: all we know so far. Front Cell Infect Microbiol. https:\/\/doi.org\/10.3389\/fcimb.2018.00401","journal-title":"Front Cell Infect Microbiol"},{"issue":"7","key":"3524_CR24","doi-asserted-by":"publisher","first-page":"4170","DOI":"10.1128\/aac.00371-16","volume":"60","author":"K Calvopi\u00f1a","year":"2016","unstructured":"Calvopi\u00f1a K, Umland KD, Rydzik AM et al (2016) Sideromimic modification of lactivicin dramatically increases potency against extensively drug-resistant Stenotrophomonas maltophilia clinical isolates. Antimicrob Agents Chemother 60(7):4170\u20134175. https:\/\/doi.org\/10.1128\/aac.00371-16","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"3524_CR25","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1080\/23744235.2018.1531145","volume":"51","author":"A Trifonova","year":"2019","unstructured":"Trifonova A, Strateva T (2019) Stenotrophomonas maltophilia - a low-grade pathogen with numerous virulence factors. Infect Dis (Lond) 51(3):168\u2013178. https:\/\/doi.org\/10.1080\/23744235.2018.1531145","journal-title":"Infect Dis (Lond)"},{"issue":"10","key":"3524_CR26","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/s0966-842x(00)88988-x","volume":"3","author":"J Travis","year":"1995","unstructured":"Travis J, Potempa J, Maeda H (1995) Are bacterial proteinases pathogenic factors? Trends Microbiol 3(10):405\u2013407. https:\/\/doi.org\/10.1016\/s0966-842x(00)88988-x","journal-title":"Trends Microbiol"},{"issue":"9","key":"3524_CR27","doi-asserted-by":"publisher","first-page":"3210","DOI":"10.1128\/iai.00546-13","volume":"81","author":"SM Karaba","year":"2013","unstructured":"Karaba SM, White RC, Cianciotto NP (2013) Stenotrophomonas maltophilia encodes a type ii protein secretion system that promotes detrimental effects on lung epithelial cells. Infect Immun 81(9):3210\u20133219. https:\/\/doi.org\/10.1128\/iai.00546-13","journal-title":"Infect Immun"},{"issue":"4","key":"3524_CR28","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s002770050275","volume":"74","author":"HA Elsner","year":"1997","unstructured":"Elsner HA, Duhrsen U, Hollwitz B et al (1997) Fatal pulmonary hemorrhage in patients with acute leukemia and fulminant pneumonia caused by Stenotrophomonas maltophilia. Ann Hematol 74(4):155\u2013161. https:\/\/doi.org\/10.1007\/s002770050275","journal-title":"Ann Hematol"},{"issue":"1","key":"3524_CR29","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ijmm.2010.07.003","volume":"301","author":"M Nicoletti","year":"2011","unstructured":"Nicoletti M, Iacobino A, Prosseda G et al (2011) Stenotrophomonas maltophilia strains from cystic fibrosis patients: genomic variability and molecular characterization of some virulence determinants. Int J Med Microbiol 301(1):34\u201343. https:\/\/doi.org\/10.1016\/j.ijmm.2010.07.003","journal-title":"Int J Med Microbiol"},{"issue":"11","key":"3524_CR30","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.4103\/ijo.IJO_314_17","volume":"65","author":"S Beri","year":"2017","unstructured":"Beri S, Shandil A, Garg R (2017) Stenotrophomonas maltophilia: an emerging entity for cluster endophthalmitis. Indian J Ophthalmol 65(11):1166\u20131171. https:\/\/doi.org\/10.4103\/ijo.IJO_314_17","journal-title":"Indian J Ophthalmol"},{"issue":"2","key":"3524_CR31","doi-asserted-by":"publisher","first-page":"326","DOI":"10.4161\/viru.27724","volume":"5","author":"R Thomas","year":"2014","unstructured":"Thomas R, Hamat RA, Neela V (2014) Extracellular enzyme profiling of Stenotrophomonas maltophilia clinical isolates. Virulence 5(2):326\u2013330. https:\/\/doi.org\/10.4161\/viru.27724","journal-title":"Virulence"},{"issue":"5","key":"3524_CR32","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1111\/j.1365-2672.2004.02248.x","volume":"96","author":"LH Travassos","year":"2004","unstructured":"Travassos LH, Pinheiro MN, Coelho FS et al (2004) Phenotypic properties, drug susceptibility and genetic relatedness of Stenotrophomonas maltophilia clinical strains from seven hospitals in Rio de Janeiro. Brazil J Appl Microbiol 96(5):1143\u20131150. https:\/\/doi.org\/10.1111\/j.1365-2672.2004.02248.x","journal-title":"Brazil J Appl Microbiol"},{"issue":"4","key":"3524_CR33","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/S0966-842X(97)01005-6","volume":"5","author":"JG Songer","year":"1997","unstructured":"Songer JG (1997) Bacterial phospholipases and their role in virulence. Trends Microbiol 5(4):156\u2013161. https:\/\/doi.org\/10.1016\/S0966-842X(97)01005-6","journal-title":"Trends Microbiol"},{"issue":"4","key":"3524_CR34","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1165\/ajrcmb\/5.4.315","volume":"5","author":"H Rahmoune","year":"1991","unstructured":"Rahmoune H, Lamblin G, Lafitte JJ et al (1991) Chondroitin sulfate in sputum from patients with cystic fibrosis and chronic bronchitis. Am J Respir Cell Mol Biol 5(4):315\u2013320. https:\/\/doi.org\/10.1165\/ajrcmb\/5.4.315","journal-title":"Am J Respir Cell Mol Biol"},{"key":"3524_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.899890","author":"C Liao","year":"2022","unstructured":"Liao C, Mao F, Qian M et al (2022) Pathogen-derived nucleases: an effective weapon for escaping extracellular traps. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2022.899890","journal-title":"Front Immunol"},{"issue":"4","key":"3524_CR36","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/j.1472-765X.2006.01965.x","volume":"43","author":"PM Figueiredo","year":"2006","unstructured":"Figueiredo PM, Furumura MT, Santos AM et al (2006) Cytotoxic activity of clinical Stenotrophomonas maltophilia. Lett Appl Microbiol 43(4):443\u2013449. https:\/\/doi.org\/10.1111\/j.1472-765X.2006.01965.x","journal-title":"Lett Appl Microbiol"},{"issue":"10","key":"3524_CR37","doi-asserted-by":"publisher","first-page":"7072","DOI":"10.1073\/pnas.092016999","volume":"99","author":"IL Lamont","year":"2002","unstructured":"Lamont IL, Beare PA, Ochsner U et al (2002) Siderophore-mediated signaling regulates virulence factor production in Pseudomonasaeruginosa. Proc Natl Acad Sci U S A 99(10):7072\u20137077. https:\/\/doi.org\/10.1073\/pnas.092016999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3524_CR38","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01906-16","author":"J Behnsen","year":"2016","unstructured":"Behnsen J, Siderophores RM (2016) More than stealing iron. MBio. https:\/\/doi.org\/10.1128\/mBio.01906-16","journal-title":"MBio"},{"issue":"Suppl 1","key":"3524_CR39","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.2166\/wh.2009.036","volume":"7","author":"A Casadevall","year":"2009","unstructured":"Casadevall A, Pirofski LA (2009) Virulence factors and their mechanisms of action: the view from a damage-response framework. J Water Health 7(Suppl 1):S2\u2013S18. https:\/\/doi.org\/10.2166\/wh.2009.036","journal-title":"J Water Health"},{"issue":"5","key":"3524_CR40","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/S1473-3099(09)70083-0","volume":"9","author":"WJ Looney","year":"2009","unstructured":"Looney WJ, Narita M, Muhlemann K (2009) Stenotrophomonas maltophilia: an emerging opportunist human pathogen. Lancet Infect Dis 9(5):312\u2013323. https:\/\/doi.org\/10.1016\/S1473-3099(09)70083-0","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"3524_CR41","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1046\/j.1462-5822.2003.00306.x","volume":"5","author":"D de Oliveira-Garcia","year":"2003","unstructured":"de Oliveira-Garcia D, Dall\u2019Agnol M, Rosales M et al (2003) Fimbriae and adherence of Stenotrophomonas maltophilia to epithelial cells and to abiotic surfaces. Cell Microbiol 5(9):625\u2013636. https:\/\/doi.org\/10.1046\/j.1462-5822.2003.00306.x","journal-title":"Cell Microbiol"},{"issue":"6","key":"3524_CR42","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.chom.2009.05.011","volume":"5","author":"KA Kline","year":"2009","unstructured":"Kline KA, Falker S, Dahlberg S et al (2009) Bacterial adhesins in host-microbe interactions. Cell Host Microbe 5(6):580\u2013592. https:\/\/doi.org\/10.1016\/j.chom.2009.05.011","journal-title":"Cell Host Microbe"},{"key":"3524_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-10-102","author":"A Pompilio","year":"2010","unstructured":"Pompilio A, Crocetta V, Confalone P et al (2010) Adhesion to and biofilm formation on IB3-1 bronchial cells by Stenotrophomonas maltophilia isolates from cystic fibrosis patients. BMC Microbiol. https:\/\/doi.org\/10.1186\/1471-2180-10-102","journal-title":"BMC Microbiol"},{"issue":"4","key":"3524_CR44","doi-asserted-by":"publisher","first-page":"R74","DOI":"10.1186\/gb-2008-9-4-r74","volume":"9","author":"LC Crossman","year":"2008","unstructured":"Crossman LC, Gould VC, Dow JM et al (2008) The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants. Genome Biol 9(4):R74. https:\/\/doi.org\/10.1186\/gb-2008-9-4-r74","journal-title":"Genome Biol"},{"issue":"5","key":"3524_CR45","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s10096-015-2323-z","volume":"34","author":"I Olsen","year":"2015","unstructured":"Olsen I (2015) Biofilm-specific antibiotic tolerance and resistance. Eur J Clin Microbiol Infect Dis 34(5):877\u2013886. https:\/\/doi.org\/10.1007\/s10096-015-2323-z","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"3524_CR46","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.tim.2013.12.004","volume":"22","author":"M Burmolle","year":"2014","unstructured":"Burmolle M, Ren D, Bjarnsholt T et al (2014) Interactions in multispecies biofilms: Do they actually matter? Trends Microbiol 22(2):84\u201391. https:\/\/doi.org\/10.1016\/j.tim.2013.12.004","journal-title":"Trends Microbiol"},{"issue":"2","key":"3524_CR47","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.femsle.2004.06.005","volume":"236","author":"KK Jefferson","year":"2004","unstructured":"Jefferson KK (2004) What drives bacteria to produce a biofilm? FEMS Microbiol Lett 236(2):163\u2013173. https:\/\/doi.org\/10.1016\/j.femsle.2004.06.005","journal-title":"FEMS Microbiol Lett"},{"key":"3524_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2021.126836","author":"WA Wicaksono","year":"2022","unstructured":"Wicaksono WA, Erschen S, Krause R et al (2022) Enhanced survival of multi-species biofilms under stress is promoted by low-abundant but antimicrobial-resistant keystone species. J Hazard Mater. https:\/\/doi.org\/10.1016\/j.jhazmat.2021.126836","journal-title":"J Hazard Mater"},{"key":"3524_CR49","doi-asserted-by":"publisher","DOI":"10.1128\/iai.00457-19","author":"MY Nas","year":"2019","unstructured":"Nas MY, White RC, DuMont AL et al (2019) Stenotrophomonas maltophilia encodes a VirB\/VirD4 type IV secretion system that modulates apoptosis in human cells and promotes competition against heterologous bacteria, including Pseudomonas aeruginosa. Infect Immun. https:\/\/doi.org\/10.1128\/iai.00457-19","journal-title":"Infect Immun"},{"key":"3524_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.00893","author":"YT Chang","year":"2015","unstructured":"Chang YT, Lin CY, Chen YH et al (2015) Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2015.00893","journal-title":"Front Microbiol"},{"key":"3524_CR51","unstructured":"Canadian Antimicrobial Resistance Alliance CANWARD Pathogens (2018). https:\/\/www.can-r.ca\/study.php?study=canw2016&year=2016"},{"issue":"11","key":"3524_CR52","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1080\/14787210.2019.1685875","volume":"17","author":"S Flores-Trevino","year":"2019","unstructured":"Flores-Trevino S, Bocanegra-Ibarias P, Camacho-Ortiz A et al (2019) Stenotrophomonas maltophilia biofilm: its role in infectious diseases. Expert Rev Anti Infect Ther 17(11):877\u2013893. https:\/\/doi.org\/10.1080\/14787210.2019.1685875","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"3","key":"3524_CR53","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/hon.898","volume":"27","author":"KV Rolston","year":"2009","unstructured":"Rolston KV (2009) New antimicrobial agents for the treatment of bacterial infections in cancer patients. Hematol Oncol 27(3):107\u2013114. https:\/\/doi.org\/10.1002\/hon.898","journal-title":"Hematol Oncol"},{"issue":"12","key":"3524_CR54","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1086\/522998","volume":"45","author":"A Safdar","year":"2007","unstructured":"Safdar A, Rolston KV (2007) Stenotrophomonas maltophilia: changing spectrum of a serious bacterial pathogen in patients with cancer. Clin Infect Dis 45(12):1602\u20131609. https:\/\/doi.org\/10.1086\/522998","journal-title":"Clin Infect Dis"},{"issue":"10","key":"3524_CR55","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/S1470-2045(08)70255-9","volume":"9","author":"S Vento","year":"2008","unstructured":"Vento S, Cainelli F, Temesgen Z (2008) Lung infections after cancer chemotherapy. Lancet Oncol 9(10):982\u2013992. https:\/\/doi.org\/10.1016\/S1470-2045(08)70255-9","journal-title":"Lancet Oncol"},{"issue":"5","key":"3524_CR56","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1164\/rccm.201009-1392OC","volume":"183","author":"V Waters","year":"2011","unstructured":"Waters V, Yau Y, Prasad S et al (2011) Stenotrophomonas maltophilia in cystic fibrosis: serologic response and effect on lung disease. Am J Respir Crit Care Med 183(5):635\u2013640. https:\/\/doi.org\/10.1164\/rccm.201009-1392OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"3524_CR57","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1136\/thx.2003.017707","volume":"59","author":"CH Goss","year":"2004","unstructured":"Goss CH, Mayer-Hamblett N, Aitken ML et al (2004) Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis. Thorax 59(11):955\u2013959. https:\/\/doi.org\/10.1136\/thx.2003.017707","journal-title":"Thorax"},{"issue":"4","key":"3524_CR58","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s15010-021-01602-z","volume":"49","author":"WH Chong","year":"2021","unstructured":"Chong WH, Saha BK, Ananthakrishnan R et al (2021) State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia. Infection 49(4):591\u2013605. https:\/\/doi.org\/10.1007\/s15010-021-01602-z","journal-title":"Infection"},{"key":"3524_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.00951","author":"A Pompilio","year":"2015","unstructured":"Pompilio A, Crocetta V, De Nicola S et al (2015) Cooperative pathogenicity in cystic fibrosis: Stenotrophomonas maltophilia modulates Pseudomonas aeruginosa virulence in mixed biofilm. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2015.00951","journal-title":"Front Microbiol"},{"issue":"2","key":"3524_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2021.106367","volume":"58","author":"SJ Junco","year":"2021","unstructured":"Junco SJ, Bowman MC, Turner RB (2021) Clinical outcomes of Stenotrophomonas maltophilia infection treated with trimethoprim\/sulfamethoxazole, minocycline, or fluoroquinolone monotherapy. Int J Antimicrob Agents 58(2):106367. https:\/\/doi.org\/10.1016\/j.ijantimicag.2021.106367","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"3524_CR61","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1128\/AAC.01324-13","volume":"58","author":"YL Wang","year":"2014","unstructured":"Wang YL, Scipione MR, Dubrovskaya Y et al (2014) Monotherapy with fluoroquinolone or trimethoprim-sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections. Antimicrob Agents Chemother 58(1):176\u2013182. https:\/\/doi.org\/10.1128\/AAC.01324-13","journal-title":"Antimicrob Agents Chemother"},{"key":"3524_CR62","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00788-19","author":"C Nys","year":"2019","unstructured":"Nys C, Cherabuddi K, Venugopalan V et al (2019) Clinical and microbiologic outcomes in patients with monomicrobial Stenotrophomonas maltophilia infections. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/AAC.00788-19","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"3524_CR63","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1093\/jac\/dkn301","volume":"62","author":"ME Falagas","year":"2008","unstructured":"Falagas ME, Valkimadi PE, Huang YT et al (2008) Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: a systematic review. J Antimicrob Chemother 62(5):889\u2013894. https:\/\/doi.org\/10.1093\/jac\/dkn301","journal-title":"J Antimicrob Chemother"},{"key":"3524_CR64","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad428","author":"PD Tamma","year":"2023","unstructured":"Tamma PD, Aitken SL, Bonomo RA et al (2023) Infectious diseases society of America 2023 guidance on the treatment of antimicrobial resistant gram-negative infections. Clin Infect Dis. https:\/\/doi.org\/10.1093\/cid\/ciad428","journal-title":"Clin Infect Dis"},{"issue":"2","key":"3524_CR65","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jmii.2011.09.028","volume":"45","author":"H Wu","year":"2012","unstructured":"Wu H, Wang JT, Shiau YR et al (2012) A multicenter surveillance of antimicrobial resistance on Stenotrophomonas maltophilia in Taiwan. J Microbiol Immunol Infect 45(2):120\u2013126. https:\/\/doi.org\/10.1016\/j.jmii.2011.09.028","journal-title":"J Microbiol Immunol Infect"},{"issue":"9","key":"3524_CR66","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1111\/j.1469-0691.2008.02061.x","volume":"14","author":"N Petrosillo","year":"2008","unstructured":"Petrosillo N, Ioannidou E, Falagas ME (2008) Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies. Clin Microbiol Infect 14(9):816\u2013827. https:\/\/doi.org\/10.1111\/j.1469-0691.2008.02061.x","journal-title":"Clin Microbiol Infect"},{"key":"3524_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10101226","author":"J Gibb","year":"2021","unstructured":"Gibb J, Wong DW (2021) Antimicrobial treatment strategies for Stenotrophomonas maltophilia: a focus on novel therapies. Antibiotics (Basel). https:\/\/doi.org\/10.3390\/antibiotics10101226","journal-title":"Antibiotics (Basel)"},{"key":"3524_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.00658","author":"MB Sanchez","year":"2015","unstructured":"Sanchez MB (2015) Antibiotic resistance in the opportunistic pathogen Stenotrophomonas maltophilia. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2015.00658","journal-title":"Front Microbiol"},{"issue":"3","key":"3524_CR69","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1177\/039463200702000311","volume":"20","author":"G Di Bonaventura","year":"2007","unstructured":"Di Bonaventura G, Prosseda G, Del Chierico F et al (2007) Molecular characterization of virulence determinants of Stenotrophomonas maltophilia strains isolated from patients affected by cystic fibrosis. Int J Immunopathol Pharmacol 20(3):529\u2013537. https:\/\/doi.org\/10.1177\/039463200702000311","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"2","key":"3524_CR70","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.diagmicrobio.2007.09.007","volume":"60","author":"CK Tan","year":"2008","unstructured":"Tan CK, Liaw SJ, Yu CJ et al (2008) Extensively drug-resistant Stenotrophomonas maltophilia in a tertiary care hospital in Taiwan: microbiologic characteristics, clinical features, and outcomes. Diagn Microbiol Infect Dis 60(2):205\u2013210. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2007.09.007","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"3","key":"3524_CR71","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/1758-2229.12384","volume":"8","author":"RM Chanyi","year":"2016","unstructured":"Chanyi RM, Koval SF, Brooke JS (2016) Stenotrophomonas maltophilia biofilm reduction by Bdellovibrio exovorus. Environ Microbiol Rep 8(3):343\u2013351. https:\/\/doi.org\/10.1111\/1758-2229.12384","journal-title":"Environ Microbiol Rep"},{"key":"3524_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2023.02.018","author":"M Dadashi","year":"2023","unstructured":"Dadashi M, Hajikhani B, Nazarinejad N et al (2023) Global prevalence and distribution of antibiotic resistance among clinical isolates of Stenotrophomonas maltophilia: a systematic review and meta-analysis. J Glob Antimicrob Resist. https:\/\/doi.org\/10.1016\/j.jgar.2023.02.018","journal-title":"J Glob Antimicrob Resist"},{"issue":"5","key":"3524_CR73","doi-asserted-by":"publisher","first-page":"364","DOI":"10.4103\/0256-4947.67073","volume":"30","author":"AJ Sameera","year":"2010","unstructured":"Sameera AJ, Javed A, Hanan B et al (2010) Prevalence of antimicrobial resistance among gram-negative isolates in an adult intensive care unit at a tertiary care center in Saudi Arabia. Ann Saudi Med 30(5):364\u2013369","journal-title":"Ann Saudi Med"},{"issue":"7","key":"3524_CR74","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1128\/JCM.36.7.1953-1958.1998","volume":"36","author":"M Denton","year":"1998","unstructured":"Denton M, Todd NJ, Kerr KG et al (1998) Molecular epidemiology of Stenotrophomonas maltophilia isolated from clinical specimens from patients with cystic fibrosis and associated environmental samples. J Clin Microbiol 36(7):1953\u20131958","journal-title":"J Clin Microbiol"},{"issue":"4","key":"3524_CR75","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1080\/003655400750045060","volume":"32","author":"K Aydin","year":"2000","unstructured":"Aydin K, Koksal I, Kaygusuz S et al (2000) Endocarditis caused by Stenotrophomonas maltophilia. Scand J Infect Dis 32(4):427\u2013430. https:\/\/doi.org\/10.1080\/003655400750045060","journal-title":"Scand J Infect Dis"},{"key":"3524_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.00241","author":"G Berg","year":"2015","unstructured":"Berg G, Martinez JL (2015) Friends or foes: can we make a distinction between beneficial and harmful strains of the Stenotrophomonas maltophilia complex? Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2015.00241","journal-title":"Front Microbiol"},{"key":"3524_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.00967","author":"P Mukherjee","year":"2016","unstructured":"Mukherjee P, Roy P (2016) Genomic potential of Stenotrophomonas maltophilia in bioremediation with an assessment of its multifaceted role in our environment. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2016.00967","journal-title":"Front Microbiol"},{"issue":"2","key":"3524_CR78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001539","volume":"3","author":"D Pages","year":"2008","unstructured":"Pages D, Rose J, Conrod S et al (2008) Heavy metal tolerance in Stenotrophomonas maltophilia. PLoS ONE 3(2):e1539. https:\/\/doi.org\/10.1371\/journal.pone.0001539","journal-title":"PLoS ONE"},{"issue":"7","key":"3524_CR79","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/nrmicro2163","volume":"7","author":"RP Ryan","year":"2009","unstructured":"Ryan RP, Monchy S, Cardinale M et al (2009) The versatility and adaptation of bacteria from the genus Stenotrophomonas. Nat Rev Microbiol 7(7):514\u2013525. https:\/\/doi.org\/10.1038\/nrmicro2163","journal-title":"Nat Rev Microbiol"},{"key":"3524_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2020.09.008","author":"J Ma","year":"2020","unstructured":"Ma J, Feng J, Shan Y et al (2020) Characteristic antimicrobial resistance of clinically isolated Stenotrophomonas maltophilia CYZ via complete genome sequence. J Glob Antimicrob Resist. https:\/\/doi.org\/10.1016\/j.jgar.2020.09.008","journal-title":"J Glob Antimicrob Resist"},{"issue":"4","key":"3524_CR81","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1128\/AAC.22.4.564","volume":"22","author":"Y Saino","year":"1982","unstructured":"Saino Y, Kobayashi F, Inoue M et al (1982) Purification and properties of inducible penicillin beta-lactamase isolated from Pseudomonas maltophilia. Antimicrob Agents Chemother 22(4):564\u2013570. https:\/\/doi.org\/10.1128\/AAC.22.4.564","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"3524_CR82","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1128\/AAC.25.3.362","volume":"25","author":"Y Saino","year":"1984","unstructured":"Saino Y, Inoue M, Mitsuhashi S (1984) Purification and properties of an inducible cephalosporinase from Pseudomonas maltophilia GN12873. Antimicrob Agents Chemother 25(3):362\u2013365. https:\/\/doi.org\/10.1128\/AAC.25.3.362","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"3524_CR83","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1128\/AAC.01485-07","volume":"52","author":"A Okazaki","year":"2008","unstructured":"Okazaki A, Avison MB (2008) Induction of L1 and L2 beta-lactamase production in Stenotrophomonas maltophilia is dependent on an AmpR-type regulator. Antimicrob Agents Chemother 52(4):1525\u20131528. https:\/\/doi.org\/10.1128\/AAC.01485-07","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"3524_CR84","doi-asserted-by":"publisher","first-page":"dlac040","DOI":"10.1093\/jacamr\/dlac040","volume":"4","author":"MF Mojica","year":"2022","unstructured":"Mojica MF, Humphries R, Lipuma JJ et al (2022) Clinical challenges treating Stenotrophomonas maltophilia infections: an update. JAC Antimicrob Resist 4(3):dlac040. https:\/\/doi.org\/10.1093\/jacamr\/dlac040","journal-title":"JAC Antimicrob Resist"},{"issue":"7","key":"3524_CR85","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.1128\/AAC.01513-08","volume":"53","author":"TC Yang","year":"2009","unstructured":"Yang TC, Huang YW, Hu RM et al (2009) AmpDI is involved in expression of the chromosomal L1 and L2 beta-lactamases of Stenotrophomonas maltophilia. Antimicrob Agents Chemother 53(7):2902\u20132907. https:\/\/doi.org\/10.1128\/AAC.01513-08","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"3524_CR86","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1038\/s41467-020-15123-0","volume":"11","author":"MI Groschel","year":"2020","unstructured":"Groschel MI, Meehan CJ, Barilar I et al (2020) The phylogenetic landscape and nosocomial spread of the multidrug-resistant opportunist Stenotrophomonas maltophilia. Nat Commun 11(1):2044. https:\/\/doi.org\/10.1038\/s41467-020-15123-0","journal-title":"Nat Commun"},{"issue":"4","key":"3524_CR87","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1093\/jac\/dkg148","volume":"51","author":"XZ Li","year":"2003","unstructured":"Li XZ, Zhang L, McKay GA et al (2003) Role of the acetyltransferase AAC(6\u2019)-Iz modifying enzyme in aminoglycoside resistance in Stenotrophomonas maltophilia. J Antimicrob Chemother 51(4):803\u2013811. https:\/\/doi.org\/10.1093\/jac\/dkg148","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"3524_CR88","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1128\/AAC.00795-06","volume":"51","author":"A Okazaki","year":"2007","unstructured":"Okazaki A, Avison MB (2007) Aph(3\u2019)-IIc, an aminoglycoside resistance determinant from Stenotrophomonas maltophilia. Antimicrob Agents Chemother 51(1):359\u2013360. https:\/\/doi.org\/10.1128\/AAC.00795-06","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"3524_CR89","doi-asserted-by":"publisher","first-page":"6324","DOI":"10.1128\/AAC.03354-14","volume":"58","author":"T Tada","year":"2014","unstructured":"Tada T, Miyoshi-Akiyama T, Dahal RK et al (2014) Identification of a novel 6\u2019-N-aminoglycoside acetyltransferase, AAC(6\u2019)-Iak, from a multidrug-resistant clinical isolate of Stenotrophomonas maltophilia. Antimicrob Agents Chemother 58(10):6324\u20136327. https:\/\/doi.org\/10.1128\/AAC.03354-14","journal-title":"Antimicrob Agents Chemother"},{"key":"3524_CR90","doi-asserted-by":"publisher","DOI":"10.3390\/biology11071044","author":"OM Zajac","year":"2022","unstructured":"Zajac OM, Tyski S, Laudy AE (2022) The contribution of efflux systems to levofloxacin resistance in Stenotrophomonas maltophilia clinical strains isolated in Warsaw, Poland. Biology (Basel). https:\/\/doi.org\/10.3390\/biology11071044","journal-title":"Biology (Basel)"},{"issue":"11","key":"3524_CR91","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1093\/jac\/dkt250","volume":"68","author":"YW Huang","year":"2013","unstructured":"Huang YW, Hu RM, Chu FY et al (2013) Characterization of a major facilitator superfamily (MFS) tripartite efflux pump EmrCABsm from Stenotrophomonas maltophilia. J Antimicrob Chemother 68(11):2498\u20132505. https:\/\/doi.org\/10.1093\/jac\/dkt250","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"3524_CR92","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0051053","volume":"7","author":"RM Hu","year":"2012","unstructured":"Hu RM, Liao ST, Huang CC et al (2012) An inducible fusaric acid tripartite efflux pump contributes to the fusaric acid resistance in Stenotrophomonas maltophilia. PLoS ONE 7(12):e51053. https:\/\/doi.org\/10.1371\/journal.pone.0051053","journal-title":"PLoS ONE"},{"issue":"4","key":"3524_CR93","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/14787210.2020.1730178","volume":"18","author":"T Gil-Gil","year":"2020","unstructured":"Gil-Gil T, Martinez JL, Blanco P (2020) Mechanisms of antimicrobial resistance in Stenotrophomonas maltophilia: a review of current knowledge. Expert Rev Anti Infect Ther 18(4):335\u2013347. https:\/\/doi.org\/10.1080\/14787210.2020.1730178","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"3","key":"3524_CR94","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1093\/jac\/dkp476","volume":"65","author":"NC Gordon","year":"2010","unstructured":"Gordon NC, Wareham DW (2010) Novel variants of the Smqnr family of quinolone resistance genes in clinical isolates of Stenotrophomonas maltophilia. J Antimicrob Chemother 65(3):483\u2013489. https:\/\/doi.org\/10.1093\/jac\/dkp476","journal-title":"J Antimicrob Chemother"},{"key":"3524_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.mib.2013.12.005","author":"ZD Dalebroux","year":"2014","unstructured":"Dalebroux ZD, Miller SI (2014) Salmonellae PhoPQ regulation of the outer membrane to resist innate immunity. Curr Opin Microbiol. https:\/\/doi.org\/10.1016\/j.mib.2013.12.005","journal-title":"Curr Opin Microbiol"},{"issue":"2","key":"3524_CR96","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/j.1574-6976.2008.00135.x","volume":"33","author":"WJ Gooderham","year":"2009","unstructured":"Gooderham WJ, Hancock RE (2009) Regulation of virulence and antibiotic resistance by two-component regulatory systems in Pseudomonas aeruginosa. FEMS Microbiol Rev 33(2):279\u2013294. https:\/\/doi.org\/10.1111\/j.1574-6976.2008.00135.x","journal-title":"FEMS Microbiol Rev"},{"issue":"12","key":"3524_CR97","doi-asserted-by":"publisher","first-page":"3196","DOI":"10.1111\/j.1462-2920.2010.02292.x","volume":"12","author":"JF Linares","year":"2010","unstructured":"Linares JF, Moreno R, Fajardo A et al (2010) The global regulator Crc modulates metabolism, susceptibility to antibiotics and virulence in Pseudomonas aeruginosa. Environ Microbiol 12(12):3196\u20133212. https:\/\/doi.org\/10.1111\/j.1462-2920.2010.02292.x","journal-title":"Environ Microbiol"},{"issue":"1","key":"3524_CR98","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1186\/s12866-020-01989-z","volume":"20","author":"HF Lu","year":"2020","unstructured":"Lu HF, Wu BK, Huang YW et al (2020) PhoPQ two-component regulatory system plays a global regulatory role in antibiotic susceptibility, physiology, stress adaptation, and virulence in Stenotrophomonas maltophilia. BMC Microbiol 20(1):312. https:\/\/doi.org\/10.1186\/s12866-020-01989-z","journal-title":"BMC Microbiol"},{"issue":"5","key":"3524_CR99","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0153753","volume":"11","author":"MC Liu","year":"2016","unstructured":"Liu MC, Tsai YL, Huang YW et al (2016) Stenotrophomonas maltophilia PhoP, a two-component response regulator, involved in antimicrobial susceptibilities. PLoS ONE 11(5):e0153753. https:\/\/doi.org\/10.1371\/journal.pone.0153753","journal-title":"PLoS ONE"},{"key":"3524_CR100","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2016.06.007","author":"S Hernando-Amado","year":"2016","unstructured":"Hernando-Amado S, Blanco P, Alcalde-Rico M et al (2016) Multidrug efflux pumps as main players in intrinsic and acquired resistance to antimicrobials. Drug Resist Updat. https:\/\/doi.org\/10.1016\/j.drup.2016.06.007","journal-title":"Drug Resist Updat"},{"issue":"3","key":"3524_CR101","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1093\/jac\/dkh094","volume":"53","author":"LL Chang","year":"2004","unstructured":"Chang LL, Chen HF, Chang CY et al (2004) Contribution of integrons, and SmeABC and SmeDEF efflux pumps to multidrug resistance in clinical isolates of Stenotrophomonas maltophilia. J Antimicrob Chemother 53(3):518\u2013521. https:\/\/doi.org\/10.1093\/jac\/dkh094","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"3524_CR102","doi-asserted-by":"publisher","first-page":"3386","DOI":"10.1128\/AAC.46.11.3386-3393.2002","volume":"46","author":"P Sanchez","year":"2002","unstructured":"Sanchez P, Alonso A, Martinez JL (2002) Cloning and characterization of SmeT, a repressor of the Stenotrophomonas maltophilia multidrug efflux pump SmeDEF. Antimicrob Agents Chemother 46(11):3386\u20133393. https:\/\/doi.org\/10.1128\/AAC.46.11.3386-3393.2002","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"3524_CR103","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1128\/CMR.00068-15","volume":"29","author":"ME Falagas","year":"2016","unstructured":"Falagas ME, Vouloumanou EK, Samonis G et al (2016) Fosfomycin. Clin Microbiol Rev 29(2):321\u2013347. https:\/\/doi.org\/10.1128\/CMR.00068-15","journal-title":"Clin Microbiol Rev"},{"key":"3524_CR104","doi-asserted-by":"publisher","DOI":"10.1128\/mSystems.00282-20","author":"T Gil-Gil","year":"2020","unstructured":"Gil-Gil T, Corona F, Martinez JL et al (2020) The inactivation of enzymes belonging to the central carbon metabolism is a novel mechanism of developing antibiotic resistance. mSystems. https:\/\/doi.org\/10.1128\/mSystems.00282-20","journal-title":"mSystems"},{"issue":"6","key":"3524_CR105","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1093\/jac\/28.6.837","volume":"28","author":"G Bonfiglio","year":"1991","unstructured":"Bonfiglio G, Livermore DM (1991) Effect of media composition on the susceptibility of Xanthomonas maltophilia to beta-lactam antibiotics. J Antimicrob Chemother 28(6):837\u2013342. https:\/\/doi.org\/10.1093\/jac\/28.6.837","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"3524_CR106","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/jac\/8.4.249","volume":"8","author":"RE Hancock","year":"1981","unstructured":"Hancock RE (1981) Aminoglycoside uptake and mode of action with special reference to streptomycin and gentamicin. I. Antagonists and mutants. J Antimicrob Chemother 8(4):249\u201376. https:\/\/doi.org\/10.1093\/jac\/8.4.249","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"3524_CR107","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1128\/AAC.36.3.669","volume":"36","author":"M Lecso-Bornet","year":"1992","unstructured":"Lecso-Bornet M, Pierre J, Sarkis-Karam D et al (1992) Susceptibility of Xanthomonas maltophilia to six quinolones and study of outer membrane proteins in resistant mutants selected in vitro. Antimicrob Agents Chemother 36(3):669\u2013671. https:\/\/doi.org\/10.1128\/AAC.36.3.669","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"3524_CR108","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1093\/jac\/36.2.317","volume":"36","author":"A Rahmati-Bahram","year":"1995","unstructured":"Rahmati-Bahram A, Magee JT, Jackson SK (1995) Growth temperature-dependent variation of cell envelope lipids and antibiotic susceptibility in Stenotrophomonas (Xanthomonas) maltophilia. J Antimicrob Chemother 36(2):317\u2013326. https:\/\/doi.org\/10.1093\/jac\/36.2.317","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"3524_CR109","doi-asserted-by":"publisher","first-page":"8.e1","DOI":"10.1016\/j.ijantimicag.2008.11.006","volume":"34","author":"JM Entenza","year":"2009","unstructured":"Entenza JM, Moreillon P (2009) Tigecycline in combination with other antimicrobials: a review of in vitro, animal and case report studies. Int J Antimicrob Agents 34(1):8.e1-8.e9. https:\/\/doi.org\/10.1016\/j.ijantimicag.2008.11.006","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"3524_CR110","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.diagmicrobio.2004.09.002","volume":"51","author":"SA Zelenitsky","year":"2005","unstructured":"Zelenitsky SA, Iacovides H, Ariano RE et al (2005) Antibiotic combinations significantly more active than monotherapy in an in vitro infection model of Stenotrophomonas maltophilia. Diagn Microbiol Infect Dis 51(1):39\u201343. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2004.09.002","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1","key":"3524_CR111","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13613-020-00715-2","volume":"10","author":"G De Pascale","year":"2020","unstructured":"De Pascale G, Lisi L, Ciotti GMP et al (2020) Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections. Ann Intensive Care 10(1):94. https:\/\/doi.org\/10.1186\/s13613-020-00715-2","journal-title":"Ann Intensive Care"},{"issue":"17","key":"3524_CR112","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.3760\/cma.j.issn.0366-6999.20140364","volume":"127","author":"Y Wu","year":"2014","unstructured":"Wu Y, Shao Z (2014) High-dosage tigecycline for Stenotrophomonas maltophilia bacteremia. Chin Med J (Engl) 127(17):3199","journal-title":"Chin Med J (Engl)"},{"key":"3524_CR113","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S425061","author":"J Wu","year":"2023","unstructured":"Wu J, Zhang G, Zhao Q et al (2023) In vitro antimicrobial activity and dose optimization of eravacycline and other tetracycline derivatives against levofloxacin-non-susceptible and\/or trimethoprim-sulfamethoxazole-resistant Stenotrophomonas maltophilia. Infect Drug Resist. https:\/\/doi.org\/10.2147\/IDR.S425061","journal-title":"Infect Drug Resist"},{"issue":"7","key":"3524_CR114","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1093\/jac\/dkaa117","volume":"75","author":"M Delgado-Valverde","year":"2020","unstructured":"Delgado-Valverde M, Conejo MDC, Serrano L et al (2020) Activity of cefiderocol against high-risk clones of multidrug-resistant enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa and Stenotrophomonas maltophilia. J Antimicrob Chemother 75(7):1840\u20131849. https:\/\/doi.org\/10.1093\/jac\/dkaa117","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"3524_CR115","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12866-021-02108-2","volume":"21","author":"Q Lin","year":"2021","unstructured":"Lin Q, Zou H, Chen X et al (2021) Avibactam potentiated the activity of both ceftazidime and aztreonam against S. maltophilia clinical isolates in vitro. BMC Microbiol 21(1):60. https:\/\/doi.org\/10.1186\/s12866-021-02108-2","journal-title":"BMC Microbiol"},{"issue":"9","key":"3524_CR116","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/j.peptides.2009.06.004","volume":"30","author":"G Maisetta","year":"2009","unstructured":"Maisetta G, Mangoni ML, Esin S et al (2009) In vitro bactericidal activity of the N-terminal fragment of the frog peptide esculentin-1b (Esc 1\u201318) in combination with conventional antibiotics against Stenotrophomonas maltophilia. Peptides 30(9):1622\u20131626. https:\/\/doi.org\/10.1016\/j.peptides.2009.06.004","journal-title":"Peptides"},{"issue":"11","key":"3524_CR117","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/j.peptides.2003.07.029","volume":"24","author":"ML Mangoni","year":"2003","unstructured":"Mangoni ML, Fiocco D, Mignogna G et al (2003) Functional characterisation of the 1\u201318 fragment of esculentin-1b, an antimicrobial peptide from Rana esculenta. Peptides 24(11):1771\u20131777. https:\/\/doi.org\/10.1016\/j.peptides.2003.07.029","journal-title":"Peptides"},{"issue":"1","key":"3524_CR118","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1128\/AAC.00796-07","volume":"52","author":"ML Mangoni","year":"2008","unstructured":"Mangoni ML, Maisetta G, Di Luca M et al (2008) Comparative analysis of the bactericidal activities of amphibian peptide analogues against multidrug-resistant nosocomial bacterial strains. Antimicrob Agents Chemother 52(1):85\u201391. https:\/\/doi.org\/10.1128\/AAC.00796-07","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"3524_CR119","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/j.1469-0691.2009.02837.x","volume":"16","author":"M Grare","year":"2010","unstructured":"Grare M, Dibama HM, Lafosse S et al (2010) Cationic compounds with activity against multidrug-resistant bacteria: interest of a new compound compared with two older antiseptics, hexamidine and chlorhexidine. Clin Microbiol Infect 16(5):432\u2013438. https:\/\/doi.org\/10.1111\/j.1469-0691.2009.02837.x","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"3524_CR120","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1128\/AAC.00691-08","volume":"53","author":"JJ LiPuma","year":"2009","unstructured":"LiPuma JJ, Rathinavelu S, Foster BK et al (2009) In vitro activities of a novel nanoemulsion against Burkholderia and other multidrug-resistant cystic fibrosis-associated bacterial species. Antimicrob Agents Chemother 53(1):249\u2013255. https:\/\/doi.org\/10.1128\/AAC.00691-08","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"3524_CR121","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/ptr.1968","volume":"21","author":"A Fabio","year":"2007","unstructured":"Fabio A, Cermelli C, Fabio G et al (2007) Screening of the antibacterial effects of a variety of essential oils on microorganisms responsible for respiratory infections. Phytother Res 21(4):374\u2013377. https:\/\/doi.org\/10.1002\/ptr.1968","journal-title":"Phytother Res"},{"key":"3524_CR122","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-394438-2.00001-3","author":"N Chanishvili","year":"2012","unstructured":"Chanishvili N (2012) Phage therapy\u2013history from Twort and d\u2019Herelle through Soviet experience to current approaches. Adv Virus Res. https:\/\/doi.org\/10.1016\/B978-0-12-394438-2.00001-3","journal-title":"Adv Virus Res"},{"issue":"2","key":"3524_CR123","doi-asserted-by":"publisher","first-page":"130","DOI":"10.4161\/bact.20757","volume":"2","author":"WC Summers","year":"2012","unstructured":"Summers WC (2012) The strange history of phage therapy. Bacteriophage 2(2):130\u2013133. https:\/\/doi.org\/10.4161\/bact.20757","journal-title":"Bacteriophage"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-023-03524-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00284-023-03524-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-023-03524-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T22:38:20Z","timestamp":1730500700000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00284-023-03524-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,13]]},"references-count":123,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["3524"],"URL":"https:\/\/doi.org\/10.1007\/s00284-023-03524-5","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"value":"0343-8651","type":"print"},{"value":"1432-0991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,13]]},"assertion":[{"value":"26 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"6"}}